- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04392336
Tracking and Improving Trust/Respect
July 22, 2022 updated by: University of Pennsylvania
Development and Validation of a Feedback System for Tracking and Improving Trust/Respect in an Economically Disadvantaged Behavioral Health Population
This study will examine the efficacy of a feedback system for providers that tracks patient trust/respect on an ongoing basis and to test the hypothesis that receiving feedback on trust/respect will lead to improvements in patient satisfaction, functioning, symptoms, and trust/respect.
.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a randomized effectiveness trial in which real-world providers will be given feedback on patient trust/respect.
Approximately 40 clinicians, and up to 180 consumers will be enlisted participate in the randomized effectiveness trial.
All enrolled patients will complete the BASIS-24, the Satisfaction with Care scale, and the Satisfaction with Social Roles and Activities Scale on handheld tablets or desktop computers at baseline.
Patients will be randomized to one of two conditions.
Patients in the first condition will attend therapy with clinicians who have received a standard automated outcome report, plus a report that contains information on the patient's trust/respect with suggestions for interventions if low/declining trust/respect is apparent.
Patients in the second condition will attend therapy and complete the same measures as patients in the first condition, but their therapists will only receive a standard automated outcome report, without any patient information on trust/respect.
At the time of the first therapy appointment and for all remaining therapy appointments, patients will complete four total measures: the new measure of trust/respect, the BASIS-24, the Satisfaction with Care scale, and the Satisfaction with Social Roles and Activities scale.
Study Type
Interventional
Enrollment (Actual)
185
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ability to read at least at the 4th grade level
- 18 years of age and older
- Willingness to participate in research.
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Trust/Respect feedback
Clinicians with consumers in this arm receive feedback on trust/respect in addition to symptom feedback.
|
This feedback includes information on the level of trust/respect that a consumer has for their clinician in addition to symptom feedback.
|
|
No Intervention: No Trust/Respect feedback
Clinicians with consumers in this arm do not receive feedback on trust/respect and only receive symptom feedback.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in PROMIS SF v2.0 scores
Time Frame: Up to 12 sessions, an average of 3 months
|
Evaluates satisfaction with social roles and activities.
Raw scores range from 4 to 20.
This is a longitudinal assessment of change between multiple time points.
|
Up to 12 sessions, an average of 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in BASIS-24 scores
Time Frame: Up to 12 sessions, an average of 3 months
|
The 24-item Behavior and Symptom Identification Scale is used to determine overall well-being.
Scores range from 0 to 4. Lower scores indicate overall better well-being.
This is a longitudinal assessment of change between multiple time points.
|
Up to 12 sessions, an average of 3 months
|
|
Change in Opinions about My Doctor/Therapist scores
Time Frame: Up to 12 sessions, an average of 3 months
|
Asks participants questions regarding trust/respect for their clinician.
Scores range from 1 to 7, with higher scores indicating greater trust/respect.
This is a longitudinal assessment of change between multiple time points.
|
Up to 12 sessions, an average of 3 months
|
|
Change in Satisfaction with Care scores
Time Frame: Up to 12 sessions, an 3 months
|
Evaluates satisfaction with care.
Raw scores range from 1 to 7.
This is a longitudinal assessment of change between multiple time points.
|
Up to 12 sessions, an 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 27, 2019
Primary Completion (Actual)
April 29, 2022
Study Completion (Actual)
April 29, 2022
Study Registration Dates
First Submitted
March 23, 2020
First Submitted That Met QC Criteria
May 12, 2020
First Posted (Actual)
May 18, 2020
Study Record Updates
Last Update Posted (Actual)
July 25, 2022
Last Update Submitted That Met QC Criteria
July 22, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 830013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Requests for data can be made through the PI.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impact of Feedback on Symptoms and Trust/Respect on Outcomes
-
Indira IVF Hospital Pvt LtdBonraybio Co. Ltd.; ADVY Chemical Private LimitedNot yet recruitingSperm DNA Fragmentation | Sperm DNA Impact on ART Outcomes | Double-strand Breaks | Double-strand Breaks and Impact on ARTIndia
-
Medical University of GdanskCompletedThe Impact of Extreme Physical Exertion on Health | The Impact of Extreme Physical Exertion on Glucose | The Impact of Extreme Physical Exertion on Respiratory System | The Impact of Extreme Physical Exertion on Joints and Muscles | The Impact of Extreme Physical Exertion on Cardiovascular... and other conditionsPoland
-
Kristina Gemzell DanielssonCompletedImpact of Contraceptive Counselling on LARC Uptake and Unplanned PregnancySweden
-
GE HealthcareCompletedGather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd TrimesterUnited States
-
University of OxfordKing's College London; University of NottinghamCompletedImpact of Masks on Oxygen LevelsUnited Kingdom
-
Simon Fraser UniversityForm Athletica Inc.CompletedEffect of Real-time Visual Feedback on Participant Compliance, Motivation, and Performance in SwimmingCanada
-
RWTH Aachen UniversityCompleted
-
Zhejiang Cancer HospitalRecruitingThe Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy IndividualsChina
-
University Hospital, ToursCompletedQuality of Work Life of Psychiatric Nurses | Impact on Quality of Care
-
The Alternative Sexualities Health Research AllianceCompletedImpact on Psychological Well-being of Involvement in Kink BehaviorsUnited States
Clinical Trials on Trust/Respect feedback
-
Columbia UniversityNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of Pittsburgh and other collaboratorsCompletedHIV/AIDS | Sexually Transmitted InfectionsUnited States
-
Lucy JonasRecruiting
-
Connecticut Children's Medical CenterNational Cancer Institute (NCI)RecruitingPediatric Cancer | Adolescent and Young Adult CancerUnited States
-
University of California, San FranciscoCenters for Disease Control and PreventionEnrolling by invitationmHealth InterventionUnited States
-
University of SheffieldEnrolling by invitation
-
Case Western Reserve UniversityNational Institute on Minority Health and Health Disparities (NIMHD)CompletedQuality of Life | Depressive SymptomsUnited States
-
University Hospitals Cleveland Medical CenterCase Western Reserve UniversityCompleted
-
The University of AkronBrown University; The Miriam Hospital; Indiana UniversityCompleted
-
Stanford UniversityEnrolling by invitationBeverage Intake | Child Health and NutritionUnited States
-
Michele StatonNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Enrolling by invitationSubstance Use Disorder (SUD)United States